

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.00285554 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.76584535 |
| 3 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.64418773 |
| 4 | vocalization behavior (GO:0071625) | 5.57622000 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.56911060 |
| 6 | synaptic vesicle maturation (GO:0016188) | 5.36088154 |
| 7 | glutamate secretion (GO:0014047) | 5.28934181 |
| 8 | locomotory exploration behavior (GO:0035641) | 5.27276044 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.20142235 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.15545026 |
| 11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.09435971 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.99549928 |
| 13 | protein localization to synapse (GO:0035418) | 4.96462994 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.90824222 |
| 15 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.83624577 |
| 16 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.72425347 |
| 17 | neuronal action potential propagation (GO:0019227) | 4.68695082 |
| 18 | neuron cell-cell adhesion (GO:0007158) | 4.67746239 |
| 19 | synaptic transmission, glutamatergic (GO:0035249) | 4.60359026 |
| 20 | regulation of synaptic vesicle transport (GO:1902803) | 4.50925168 |
| 21 | glutamate receptor signaling pathway (GO:0007215) | 4.50688166 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.43801333 |
| 23 | neuron-neuron synaptic transmission (GO:0007270) | 4.40107519 |
| 24 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.32542353 |
| 25 | neurotransmitter secretion (GO:0007269) | 4.28579125 |
| 26 | positive regulation of synapse maturation (GO:0090129) | 4.24469188 |
| 27 | exploration behavior (GO:0035640) | 4.17373559 |
| 28 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.10820635 |
| 29 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.98433396 |
| 30 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.97767437 |
| 31 | sodium ion export (GO:0071436) | 3.93431309 |
| 32 | positive regulation of membrane potential (GO:0045838) | 3.93175230 |
| 33 | regulation of synapse structural plasticity (GO:0051823) | 3.92076614 |
| 34 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.92025086 |
| 35 | axon ensheathment in central nervous system (GO:0032291) | 3.88915185 |
| 36 | central nervous system myelination (GO:0022010) | 3.88915185 |
| 37 | regulation of postsynaptic membrane potential (GO:0060078) | 3.88087877 |
| 38 | long-term synaptic potentiation (GO:0060291) | 3.84982503 |
| 39 | regulation of synaptic plasticity (GO:0048167) | 3.84917791 |
| 40 | long-term memory (GO:0007616) | 3.83563335 |
| 41 | presynaptic membrane assembly (GO:0097105) | 3.75803859 |
| 42 | synaptic vesicle endocytosis (GO:0048488) | 3.69847105 |
| 43 | gamma-aminobutyric acid transport (GO:0015812) | 3.68749245 |
| 44 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.59932161 |
| 45 | L-amino acid import (GO:0043092) | 3.58967840 |
| 46 | presynaptic membrane organization (GO:0097090) | 3.58796561 |
| 47 | postsynaptic membrane organization (GO:0001941) | 3.58700724 |
| 48 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.58432877 |
| 49 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.58411256 |
| 50 | cellular potassium ion homeostasis (GO:0030007) | 3.57960950 |
| 51 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.57027915 |
| 52 | transmission of nerve impulse (GO:0019226) | 3.54896363 |
| 53 | regulation of neurotransmitter secretion (GO:0046928) | 3.53423695 |
| 54 | dendritic spine morphogenesis (GO:0060997) | 3.53314135 |
| 55 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.51699544 |
| 56 | neurotransmitter transport (GO:0006836) | 3.50513535 |
| 57 | cerebellar granule cell differentiation (GO:0021707) | 3.48101513 |
| 58 | serotonin metabolic process (GO:0042428) | 3.47560525 |
| 59 | potassium ion import (GO:0010107) | 3.47455460 |
| 60 | neuromuscular synaptic transmission (GO:0007274) | 3.46196409 |
| 61 | neuron recognition (GO:0008038) | 3.44670370 |
| 62 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.44116267 |
| 63 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.41744121 |
| 64 | neuronal ion channel clustering (GO:0045161) | 3.41428938 |
| 65 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.39594006 |
| 66 | regulation of synapse maturation (GO:0090128) | 3.39268381 |
| 67 | response to histamine (GO:0034776) | 3.38696349 |
| 68 | potassium ion homeostasis (GO:0055075) | 3.35803215 |
| 69 | behavioral defense response (GO:0002209) | 3.32606436 |
| 70 | behavioral fear response (GO:0001662) | 3.32606436 |
| 71 | membrane depolarization (GO:0051899) | 3.32335997 |
| 72 | layer formation in cerebral cortex (GO:0021819) | 3.31719790 |
| 73 | proline transport (GO:0015824) | 3.26437319 |
| 74 | regulation of neurotransmitter transport (GO:0051588) | 3.25662044 |
| 75 | regulation of glutamate secretion (GO:0014048) | 3.25382747 |
| 76 | positive regulation of neurotransmitter transport (GO:0051590) | 3.24031034 |
| 77 | regulation of vesicle fusion (GO:0031338) | 3.23965422 |
| 78 | regulation of neurotransmitter levels (GO:0001505) | 3.23509719 |
| 79 | neurotransmitter uptake (GO:0001504) | 3.22757291 |
| 80 | membrane depolarization during action potential (GO:0086010) | 3.20369309 |
| 81 | innervation (GO:0060384) | 3.17852634 |
| 82 | auditory behavior (GO:0031223) | 3.16924719 |
| 83 | neuromuscular process controlling balance (GO:0050885) | 3.16211914 |
| 84 | regulation of synaptic transmission (GO:0050804) | 3.15537316 |
| 85 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.15110043 |
| 86 | primary amino compound metabolic process (GO:1901160) | 3.15044864 |
| 87 | fear response (GO:0042596) | 3.14974214 |
| 88 | learning (GO:0007612) | 3.14699304 |
| 89 | positive regulation of synaptic transmission (GO:0050806) | 3.13404667 |
| 90 | synaptic transmission (GO:0007268) | 3.13070284 |
| 91 | long term synaptic depression (GO:0060292) | 3.12739694 |
| 92 | behavioral response to cocaine (GO:0048148) | 3.12588845 |
| 93 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.12352218 |
| 94 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.11758418 |
| 95 | membrane hyperpolarization (GO:0060081) | 3.11090918 |
| 96 | regulation of dendritic spine development (GO:0060998) | 3.08116663 |
| 97 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.08075412 |
| 98 | regulation of female receptivity (GO:0045924) | 3.08007750 |
| 99 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.06843333 |
| 100 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.06839865 |
| 101 | axonal fasciculation (GO:0007413) | 3.06687302 |
| 102 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.06497657 |
| 103 | activation of protein kinase A activity (GO:0034199) | 3.04262687 |
| 104 | startle response (GO:0001964) | 3.03974985 |
| 105 | cellular sodium ion homeostasis (GO:0006883) | 3.03743939 |
| 106 | response to auditory stimulus (GO:0010996) | 3.02863991 |
| 107 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.00785144 |
| 108 | amino acid import (GO:0043090) | 2.99718926 |
| 109 | neuromuscular process controlling posture (GO:0050884) | 2.99689188 |
| 110 | synapse assembly (GO:0007416) | 2.98733351 |
| 111 | negative regulation of amino acid transport (GO:0051956) | 2.98692996 |
| 112 | behavioral response to nicotine (GO:0035095) | 2.98611870 |
| 113 | adult walking behavior (GO:0007628) | 2.97916646 |
| 114 | dendritic spine organization (GO:0097061) | 2.97062919 |
| 115 | mechanosensory behavior (GO:0007638) | 2.96829122 |
| 116 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.96515986 |
| 117 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.96209785 |
| 118 | female mating behavior (GO:0060180) | 2.96153928 |
| 119 | positive regulation of dendritic spine development (GO:0060999) | 2.95938297 |
| 120 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.94929401 |
| 121 | potassium ion transmembrane transport (GO:0071805) | 2.89759501 |
| 122 | cellular potassium ion transport (GO:0071804) | 2.89759501 |
| 123 | cell differentiation in hindbrain (GO:0021533) | 2.88646328 |
| 124 | acidic amino acid transport (GO:0015800) | 2.86768090 |
| 125 | neuromuscular process (GO:0050905) | 2.86445284 |
| 126 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.86347691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.24453444 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.93746422 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.18014372 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.11529250 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.08904620 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.76357642 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.70672794 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.70672794 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.66261439 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.65537432 |
| 11 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.60488954 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.53085771 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.51530410 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.47295378 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.46569618 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.45784531 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.35468833 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.34771917 |
| 19 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.25386357 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.21849032 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.21814231 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.20735979 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.09704139 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.02562392 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.95696983 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.90485633 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.88699242 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.86790349 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.83099753 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.82341854 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.79791828 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77268808 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.75622180 |
| 34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75390194 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68120634 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.66310646 |
| 37 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.55319387 |
| 38 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.46752854 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45714471 |
| 40 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44631608 |
| 41 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42873960 |
| 42 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.42224238 |
| 43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.40561743 |
| 44 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.38296009 |
| 45 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37024445 |
| 46 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35461721 |
| 47 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32008158 |
| 48 | AR_25329375_ChIP-Seq_VCAP_Human | 1.31884341 |
| 49 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31451917 |
| 50 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.30213268 |
| 51 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28858602 |
| 52 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.28540677 |
| 53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26459760 |
| 54 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.26181402 |
| 55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25550208 |
| 56 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.23235358 |
| 57 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.21458388 |
| 58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.20918679 |
| 59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20826747 |
| 60 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20555409 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.20329189 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19874534 |
| 63 | AR_19668381_ChIP-Seq_PC3_Human | 1.18700468 |
| 64 | FUS_26573619_Chip-Seq_HEK293_Human | 1.15248501 |
| 65 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.14006189 |
| 66 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13970317 |
| 67 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13793456 |
| 68 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08645447 |
| 69 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07862754 |
| 70 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07667255 |
| 71 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06064015 |
| 72 | VDR_22108803_ChIP-Seq_LS180_Human | 1.05750589 |
| 73 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05748388 |
| 74 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05693650 |
| 75 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.04892531 |
| 76 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04031760 |
| 77 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03859241 |
| 78 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03076638 |
| 79 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02164947 |
| 80 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.01121759 |
| 81 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00532395 |
| 82 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.00111689 |
| 83 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99271225 |
| 84 | JUN_21703547_ChIP-Seq_K562_Human | 0.96780724 |
| 85 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95795014 |
| 86 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95261099 |
| 87 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95261099 |
| 88 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94644564 |
| 89 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93944614 |
| 90 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.93841826 |
| 91 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.93726905 |
| 92 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93496409 |
| 93 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.93159101 |
| 94 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93081729 |
| 95 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91525691 |
| 96 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90544337 |
| 97 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90501920 |
| 98 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.90087277 |
| 99 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89671787 |
| 100 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.89616586 |
| 101 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.88911406 |
| 102 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88812455 |
| 103 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87323550 |
| 104 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87225808 |
| 105 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.86297767 |
| 106 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.84108623 |
| 107 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.83932462 |
| 108 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.82898106 |
| 109 | KDM2B_26808549_Chip-Seq_REH_Human | 0.82693474 |
| 110 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.81733269 |
| 111 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.80682874 |
| 112 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.80277104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.57396420 |
| 2 | MP0003880_abnormal_central_pattern | 5.35812117 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.20643005 |
| 4 | MP0004270_analgesia | 3.53361433 |
| 5 | MP0009745_abnormal_behavioral_response | 3.50596310 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.41493330 |
| 7 | MP0002064_seizures | 3.26992785 |
| 8 | MP0009046_muscle_twitch | 3.12948602 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.08926620 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.89876928 |
| 11 | MP0002272_abnormal_nervous_system | 2.75543545 |
| 12 | MP0002822_catalepsy | 2.71579319 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.59826677 |
| 14 | MP0001486_abnormal_startle_reflex | 2.57208858 |
| 15 | MP0002736_abnormal_nociception_after | 2.53415876 |
| 16 | MP0002735_abnormal_chemical_nociception | 2.40483216 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.31620088 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.31182728 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.30327454 |
| 20 | MP0002067_abnormal_sensory_capabilities | 2.05441646 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 1.95788090 |
| 22 | MP0001970_abnormal_pain_threshold | 1.91715007 |
| 23 | MP0008569_lethality_at_weaning | 1.88724413 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.87559888 |
| 25 | MP0003879_abnormal_hair_cell | 1.84540359 |
| 26 | MP0002184_abnormal_innervation | 1.82986380 |
| 27 | MP0005646_abnormal_pituitary_gland | 1.79954814 |
| 28 | MP0001984_abnormal_olfaction | 1.79425237 |
| 29 | MP0000778_abnormal_nervous_system | 1.75891162 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.71188864 |
| 31 | MP0004924_abnormal_behavior | 1.66421188 |
| 32 | MP0005386_behavior/neurological_phenoty | 1.66421188 |
| 33 | MP0003787_abnormal_imprinting | 1.64312795 |
| 34 | MP0004811_abnormal_neuron_physiology | 1.63882609 |
| 35 | MP0003329_amyloid_beta_deposits | 1.61579645 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.59489106 |
| 37 | MP0006276_abnormal_autonomic_nervous | 1.55011130 |
| 38 | MP0004858_abnormal_nervous_system | 1.46941076 |
| 39 | MP0000955_abnormal_spinal_cord | 1.45803917 |
| 40 | MP0004885_abnormal_endolymph | 1.44024515 |
| 41 | MP0002882_abnormal_neuron_morphology | 1.42588368 |
| 42 | MP0001529_abnormal_vocalization | 1.42414320 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.42068602 |
| 44 | MP0001905_abnormal_dopamine_level | 1.40549886 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.40335313 |
| 46 | MP0003283_abnormal_digestive_organ | 1.37424912 |
| 47 | MP0004142_abnormal_muscle_tone | 1.30973690 |
| 48 | MP0003633_abnormal_nervous_system | 1.30150260 |
| 49 | MP0001188_hyperpigmentation | 1.22627567 |
| 50 | MP0003123_paternal_imprinting | 1.21959460 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.21149777 |
| 52 | MP0004147_increased_porphyrin_level | 1.20191994 |
| 53 | MP0003122_maternal_imprinting | 1.18434460 |
| 54 | MP0003631_nervous_system_phenotype | 1.13602567 |
| 55 | MP0005551_abnormal_eye_electrophysiolog | 1.09660992 |
| 56 | MP0002152_abnormal_brain_morphology | 1.09236847 |
| 57 | MP0000569_abnormal_digit_pigmentation | 1.08031423 |
| 58 | MP0004742_abnormal_vestibular_system | 1.06317050 |
| 59 | MP0004145_abnormal_muscle_electrophysio | 1.04460656 |
| 60 | MP0010386_abnormal_urinary_bladder | 1.01600304 |
| 61 | MP0002229_neurodegeneration | 1.00958505 |
| 62 | MP0003121_genomic_imprinting | 1.00784997 |
| 63 | MP0002876_abnormal_thyroid_physiology | 0.97470949 |
| 64 | MP0001963_abnormal_hearing_physiology | 0.94983315 |
| 65 | MP0002069_abnormal_eating/drinking_beha | 0.92772451 |
| 66 | MP0001986_abnormal_taste_sensitivity | 0.92753481 |
| 67 | MP0008872_abnormal_physiological_respon | 0.92668195 |
| 68 | MP0002837_dystrophic_cardiac_calcinosis | 0.91549582 |
| 69 | MP0001485_abnormal_pinna_reflex | 0.89346126 |
| 70 | MP0003136_yellow_coat_color | 0.88489249 |
| 71 | MP0004085_abnormal_heartbeat | 0.86968646 |
| 72 | MP0005171_absent_coat_pigmentation | 0.86263944 |
| 73 | MP0000751_myopathy | 0.85462399 |
| 74 | MP0005394_taste/olfaction_phenotype | 0.84884846 |
| 75 | MP0005499_abnormal_olfactory_system | 0.84884846 |
| 76 | MP0008874_decreased_physiological_sensi | 0.83761092 |
| 77 | MP0004133_heterotaxia | 0.81679397 |
| 78 | MP0001177_atelectasis | 0.81632447 |
| 79 | MP0003632_abnormal_nervous_system | 0.81306235 |
| 80 | MP0002752_abnormal_somatic_nervous | 0.80510687 |
| 81 | MP0000013_abnormal_adipose_tissue | 0.79600317 |
| 82 | MP0004215_abnormal_myocardial_fiber | 0.78679073 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.76571893 |
| 84 | MP0000631_abnormal_neuroendocrine_gland | 0.75818432 |
| 85 | MP0003634_abnormal_glial_cell | 0.75162216 |
| 86 | MP0003195_calcinosis | 0.74661640 |
| 87 | MP0004484_altered_response_of | 0.73679893 |
| 88 | MP0006292_abnormal_olfactory_placode | 0.73491395 |
| 89 | MP0005535_abnormal_body_temperature | 0.73168450 |
| 90 | MP0005253_abnormal_eye_physiology | 0.72553944 |
| 91 | MP0003646_muscle_fatigue | 0.72318683 |
| 92 | MP0002102_abnormal_ear_morphology | 0.70447001 |
| 93 | MP0000920_abnormal_myelination | 0.68736769 |
| 94 | MP0003075_altered_response_to | 0.66588466 |
| 95 | MP0001664_abnormal_digestion | 0.66103950 |
| 96 | MP0002090_abnormal_vision | 0.64510053 |
| 97 | MP0002638_abnormal_pupillary_reflex | 0.63946609 |
| 98 | MP0005379_endocrine/exocrine_gland_phen | 0.62855022 |
| 99 | MP0002653_abnormal_ependyma_morphology | 0.62362360 |
| 100 | MP0003938_abnormal_ear_development | 0.61981747 |
| 101 | MP0004043_abnormal_pH_regulation | 0.60726188 |
| 102 | MP0000604_amyloidosis | 0.60511584 |
| 103 | MP0000026_abnormal_inner_ear | 0.58966987 |
| 104 | MP0006072_abnormal_retinal_apoptosis | 0.57908811 |
| 105 | MP0004130_abnormal_muscle_cell | 0.57877080 |
| 106 | MP0003690_abnormal_glial_cell | 0.56942652 |
| 107 | MP0008877_abnormal_DNA_methylation | 0.56601954 |
| 108 | MP0001756_abnormal_urination | 0.56260245 |
| 109 | MP0003861_abnormal_nervous_system | 0.54807765 |
| 110 | MP0002928_abnormal_bile_duct | 0.54781158 |
| 111 | MP0003137_abnormal_impulse_conducting | 0.53684314 |
| 112 | MP0002163_abnormal_gland_morphology | 0.53399869 |
| 113 | MP0001943_abnormal_respiration | 0.52674006 |
| 114 | MP0003183_abnormal_peptide_metabolism | 0.52476910 |
| 115 | MP0010769_abnormal_survival | 0.51834181 |
| 116 | MP0010770_preweaning_lethality | 0.50768846 |
| 117 | MP0002082_postnatal_lethality | 0.50768846 |
| 118 | MP0005409_darkened_coat_color | 0.50153985 |
| 119 | MP0010768_mortality/aging | 0.49171259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.65874265 |
| 2 | Myokymia (HP:0002411) | 6.80038652 |
| 3 | Focal seizures (HP:0007359) | 5.92381936 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.54641422 |
| 5 | Atonic seizures (HP:0010819) | 5.30979283 |
| 6 | Visual hallucinations (HP:0002367) | 5.28128361 |
| 7 | Febrile seizures (HP:0002373) | 5.11280752 |
| 8 | Absence seizures (HP:0002121) | 4.51258258 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.51089603 |
| 10 | Dialeptic seizures (HP:0011146) | 4.27627192 |
| 11 | Hyperventilation (HP:0002883) | 4.10439852 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.92115156 |
| 13 | Broad-based gait (HP:0002136) | 3.80935421 |
| 14 | Action tremor (HP:0002345) | 3.78025207 |
| 15 | Gaze-evoked nystagmus (HP:0000640) | 3.65351704 |
| 16 | Amblyopia (HP:0000646) | 3.29991863 |
| 17 | Dysdiadochokinesis (HP:0002075) | 3.27252794 |
| 18 | Abnormality of the lower motor neuron (HP:0002366) | 3.26616746 |
| 19 | Poor eye contact (HP:0000817) | 3.25636931 |
| 20 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.23191486 |
| 21 | Dysmetria (HP:0001310) | 3.12197584 |
| 22 | Truncal ataxia (HP:0002078) | 3.04117484 |
| 23 | Depression (HP:0000716) | 2.95658809 |
| 24 | Ankle clonus (HP:0011448) | 2.95160503 |
| 25 | Supranuclear gaze palsy (HP:0000605) | 2.94246710 |
| 26 | Anxiety (HP:0000739) | 2.92538357 |
| 27 | Impaired social interactions (HP:0000735) | 2.85476841 |
| 28 | Abnormal social behavior (HP:0012433) | 2.85476841 |
| 29 | Abnormal eating behavior (HP:0100738) | 2.85033546 |
| 30 | Scanning speech (HP:0002168) | 2.84016443 |
| 31 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.78886363 |
| 32 | Impaired smooth pursuit (HP:0007772) | 2.78637376 |
| 33 | Epileptiform EEG discharges (HP:0011182) | 2.76747944 |
| 34 | Genetic anticipation (HP:0003743) | 2.69643087 |
| 35 | Akinesia (HP:0002304) | 2.66134668 |
| 36 | Cerebral hypomyelination (HP:0006808) | 2.65323731 |
| 37 | Drooling (HP:0002307) | 2.60802882 |
| 38 | Excessive salivation (HP:0003781) | 2.60802882 |
| 39 | Hemiparesis (HP:0001269) | 2.55568515 |
| 40 | EEG with generalized epileptiform discharges (HP:0011198) | 2.52487811 |
| 41 | Postural instability (HP:0002172) | 2.42851875 |
| 42 | Spastic gait (HP:0002064) | 2.42664978 |
| 43 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.38884366 |
| 44 | Dysmetric saccades (HP:0000641) | 2.38743648 |
| 45 | Stereotypic behavior (HP:0000733) | 2.37643657 |
| 46 | Absent speech (HP:0001344) | 2.34033060 |
| 47 | Hypsarrhythmia (HP:0002521) | 2.34011851 |
| 48 | Torticollis (HP:0000473) | 2.33297112 |
| 49 | Diplopia (HP:0000651) | 2.31645337 |
| 50 | Abnormality of binocular vision (HP:0011514) | 2.31645337 |
| 51 | Focal dystonia (HP:0004373) | 2.30510928 |
| 52 | Termporal pattern (HP:0011008) | 2.28272167 |
| 53 | Insidious onset (HP:0003587) | 2.28272167 |
| 54 | Urinary urgency (HP:0000012) | 2.27355726 |
| 55 | Bradykinesia (HP:0002067) | 2.27048581 |
| 56 | Intention tremor (HP:0002080) | 2.26834165 |
| 57 | Cerebral inclusion bodies (HP:0100314) | 2.24585519 |
| 58 | Pheochromocytoma (HP:0002666) | 2.23546047 |
| 59 | Impaired vibratory sensation (HP:0002495) | 2.23357817 |
| 60 | Gait imbalance (HP:0002141) | 2.20637373 |
| 61 | Progressive inability to walk (HP:0002505) | 2.19545904 |
| 62 | Fetal akinesia sequence (HP:0001989) | 2.16031079 |
| 63 | Annular pancreas (HP:0001734) | 2.14895822 |
| 64 | Hemiplegia (HP:0002301) | 2.13685977 |
| 65 | Mutism (HP:0002300) | 2.10600078 |
| 66 | Abnormality of the corticospinal tract (HP:0002492) | 2.10177470 |
| 67 | Status epilepticus (HP:0002133) | 2.09461904 |
| 68 | Delusions (HP:0000746) | 2.07615814 |
| 69 | Sleep apnea (HP:0010535) | 2.07514780 |
| 70 | Generalized myoclonic seizures (HP:0002123) | 2.06503072 |
| 71 | Incomplete penetrance (HP:0003829) | 2.03745094 |
| 72 | Lower limb muscle weakness (HP:0007340) | 2.03408131 |
| 73 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.02042677 |
| 74 | Congenital stationary night blindness (HP:0007642) | 2.01932118 |
| 75 | Inability to walk (HP:0002540) | 2.01536294 |
| 76 | Neurofibrillary tangles (HP:0002185) | 2.01452592 |
| 77 | Craniofacial dystonia (HP:0012179) | 2.00947457 |
| 78 | Gait ataxia (HP:0002066) | 2.00091605 |
| 79 | Hypomagnesemia (HP:0002917) | 1.99757143 |
| 80 | Blue irides (HP:0000635) | 1.98635122 |
| 81 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.98500014 |
| 82 | Polyphagia (HP:0002591) | 1.97571981 |
| 83 | Protruding tongue (HP:0010808) | 1.97385419 |
| 84 | Nephronophthisis (HP:0000090) | 1.94852293 |
| 85 | Congenital primary aphakia (HP:0007707) | 1.93896256 |
| 86 | Neuroendocrine neoplasm (HP:0100634) | 1.93407991 |
| 87 | CNS hypomyelination (HP:0003429) | 1.92579080 |
| 88 | Limb dystonia (HP:0002451) | 1.92439023 |
| 89 | Specific learning disability (HP:0001328) | 1.91414844 |
| 90 | Spastic tetraparesis (HP:0001285) | 1.88906577 |
| 91 | Tetraplegia (HP:0002445) | 1.87845504 |
| 92 | Increased circulating renin level (HP:0000848) | 1.87495046 |
| 93 | Spastic tetraplegia (HP:0002510) | 1.87440362 |
| 94 | Megalencephaly (HP:0001355) | 1.86696974 |
| 95 | Ventricular fibrillation (HP:0001663) | 1.86175277 |
| 96 | Medial flaring of the eyebrow (HP:0010747) | 1.85196828 |
| 97 | Clonus (HP:0002169) | 1.85030326 |
| 98 | Abnormality of midbrain morphology (HP:0002418) | 1.84181201 |
| 99 | Molar tooth sign on MRI (HP:0002419) | 1.84181201 |
| 100 | Abnormal drinking behavior (HP:0030082) | 1.83670227 |
| 101 | Polydipsia (HP:0001959) | 1.83670227 |
| 102 | Nephrogenic diabetes insipidus (HP:0009806) | 1.80947676 |
| 103 | Abnormality of salivation (HP:0100755) | 1.78766524 |
| 104 | Thickened helices (HP:0000391) | 1.76989684 |
| 105 | Papilledema (HP:0001085) | 1.75303655 |
| 106 | Psychosis (HP:0000709) | 1.74072485 |
| 107 | Agitation (HP:0000713) | 1.73760329 |
| 108 | Abnormality of saccadic eye movements (HP:0000570) | 1.73290848 |
| 109 | Retinal dysplasia (HP:0007973) | 1.73145926 |
| 110 | Type II lissencephaly (HP:0007260) | 1.71845022 |
| 111 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.71301697 |
| 112 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.71301697 |
| 113 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.71235186 |
| 114 | Absent/shortened dynein arms (HP:0200106) | 1.71235186 |
| 115 | Prolonged QT interval (HP:0001657) | 1.70059286 |
| 116 | Abnormality of macular pigmentation (HP:0008002) | 1.66364685 |
| 117 | Syncope (HP:0001279) | 1.66023681 |
| 118 | Abnormal EKG (HP:0003115) | 1.65179917 |
| 119 | Limb ataxia (HP:0002070) | 1.65177001 |
| 120 | Resting tremor (HP:0002322) | 1.63769587 |
| 121 | Pointed chin (HP:0000307) | 1.63687622 |
| 122 | Muscular hypotonia of the trunk (HP:0008936) | 1.63500973 |
| 123 | Abnormality of magnesium homeostasis (HP:0004921) | 1.61897393 |
| 124 | Rapidly progressive (HP:0003678) | 1.61515036 |
| 125 | Thyroid-stimulating hormone excess (HP:0002925) | 1.59068006 |
| 126 | Abnormality of the renal medulla (HP:0100957) | 1.58817199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.84602278 |
| 2 | NTRK3 | 4.81592222 |
| 3 | MAP3K9 | 3.19273328 |
| 4 | CASK | 3.16016998 |
| 5 | MAP3K4 | 2.95216697 |
| 6 | DAPK2 | 2.68439423 |
| 7 | MAP2K7 | 2.66537197 |
| 8 | MINK1 | 2.46187602 |
| 9 | MAP3K12 | 2.06565661 |
| 10 | PRPF4B | 2.01078543 |
| 11 | MARK1 | 2.00335290 |
| 12 | KSR2 | 2.00240455 |
| 13 | PLK2 | 1.96103160 |
| 14 | PAK6 | 1.93805442 |
| 15 | FRK | 1.91229191 |
| 16 | DAPK1 | 1.89839496 |
| 17 | PRKD3 | 1.89342866 |
| 18 | NTRK2 | 1.86678733 |
| 19 | MAP2K4 | 1.86524658 |
| 20 | RIPK4 | 1.82926861 |
| 21 | KSR1 | 1.73461458 |
| 22 | ARAF | 1.65551143 |
| 23 | GRK5 | 1.59086912 |
| 24 | CAMKK1 | 1.58991533 |
| 25 | CDK19 | 1.57895851 |
| 26 | CDK5 | 1.44349074 |
| 27 | PNCK | 1.41914842 |
| 28 | NTRK1 | 1.31988743 |
| 29 | MAPK13 | 1.28587738 |
| 30 | PRKCG | 1.27200034 |
| 31 | PTK2B | 1.25147577 |
| 32 | TNIK | 1.24679130 |
| 33 | FES | 1.18719375 |
| 34 | SGK223 | 1.18478933 |
| 35 | SGK494 | 1.18478933 |
| 36 | BMPR2 | 1.16898374 |
| 37 | STK38 | 1.14899575 |
| 38 | CAMKK2 | 1.13589433 |
| 39 | AKT3 | 1.13536218 |
| 40 | CAMK2A | 1.11765993 |
| 41 | MAP3K13 | 1.11621125 |
| 42 | SIK3 | 1.09878284 |
| 43 | MAP3K2 | 1.06486159 |
| 44 | CAMK2B | 1.05850157 |
| 45 | BMPR1B | 1.04183818 |
| 46 | OXSR1 | 1.02213674 |
| 47 | ADRBK2 | 1.02208964 |
| 48 | SGK2 | 1.00958056 |
| 49 | CCNB1 | 0.98400979 |
| 50 | UHMK1 | 0.93752593 |
| 51 | CDK18 | 0.91260147 |
| 52 | SIK2 | 0.91151295 |
| 53 | CAMK1 | 0.90927721 |
| 54 | NME1 | 0.90022765 |
| 55 | INSRR | 0.87796393 |
| 56 | GRK1 | 0.87424272 |
| 57 | CDK15 | 0.84647527 |
| 58 | RAF1 | 0.84473017 |
| 59 | FGFR2 | 0.84195996 |
| 60 | MAP4K2 | 0.82575852 |
| 61 | CDK14 | 0.80378563 |
| 62 | PKN1 | 0.77601587 |
| 63 | DYRK2 | 0.76129770 |
| 64 | DYRK1A | 0.76023066 |
| 65 | TYRO3 | 0.74072190 |
| 66 | BRAF | 0.73457302 |
| 67 | LIMK1 | 0.73389583 |
| 68 | CDK11A | 0.73230028 |
| 69 | CAMK1G | 0.72715698 |
| 70 | PRKCH | 0.72437391 |
| 71 | SGK3 | 0.72182052 |
| 72 | PINK1 | 0.70624168 |
| 73 | STK11 | 0.70338115 |
| 74 | SGK1 | 0.70026012 |
| 75 | MAP2K6 | 0.70004183 |
| 76 | MARK2 | 0.67629026 |
| 77 | CAMK1D | 0.67320411 |
| 78 | WNK4 | 0.67095400 |
| 79 | BCKDK | 0.65649709 |
| 80 | LATS2 | 0.61453422 |
| 81 | TAOK1 | 0.61172651 |
| 82 | PRKCE | 0.60232693 |
| 83 | CAMK2D | 0.59531614 |
| 84 | FGR | 0.59508060 |
| 85 | PHKG1 | 0.57884139 |
| 86 | PHKG2 | 0.57884139 |
| 87 | PAK3 | 0.56788743 |
| 88 | BCR | 0.56452272 |
| 89 | ALK | 0.54517099 |
| 90 | PDK1 | 0.53993300 |
| 91 | RET | 0.52358609 |
| 92 | FER | 0.51003776 |
| 93 | CAMK2G | 0.50913791 |
| 94 | PDPK1 | 0.50372435 |
| 95 | MAP3K6 | 0.49819299 |
| 96 | MAP3K1 | 0.49722208 |
| 97 | CSNK1G2 | 0.49108489 |
| 98 | DAPK3 | 0.46515795 |
| 99 | MUSK | 0.45321251 |
| 100 | CSNK1G3 | 0.45059760 |
| 101 | RPS6KA3 | 0.44433765 |
| 102 | CAMK4 | 0.44206344 |
| 103 | TNK2 | 0.44180470 |
| 104 | CSNK1D | 0.43602832 |
| 105 | PRKG1 | 0.43225717 |
| 106 | CSNK1A1 | 0.41371646 |
| 107 | MAP2K1 | 0.41339985 |
| 108 | CSNK1G1 | 0.40565915 |
| 109 | PRKCZ | 0.39207403 |
| 110 | PRKG2 | 0.38980804 |
| 111 | CDC42BPA | 0.38104651 |
| 112 | NEK6 | 0.37997447 |
| 113 | WNK1 | 0.37588091 |
| 114 | MAPK10 | 0.35842899 |
| 115 | CSNK1E | 0.35334457 |
| 116 | WNK3 | 0.35137114 |
| 117 | MAPK12 | 0.35065554 |
| 118 | FYN | 0.34045400 |
| 119 | PRKAA1 | 0.33570123 |
| 120 | PRKACA | 0.33042189 |
| 121 | ADRBK1 | 0.32918145 |
| 122 | STK39 | 0.32864803 |
| 123 | ERBB2 | 0.31599632 |
| 124 | PRKCA | 0.30820594 |
| 125 | LMTK2 | 0.30500487 |
| 126 | MAP3K7 | 0.30290942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.01882145 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.58997396 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.92544690 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.88763051 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.86814948 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.86486303 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.74098075 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.68066848 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.63916920 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.63101698 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.23116080 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.21210391 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.09642031 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.03915688 |
| 15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.02853978 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.93287860 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87800850 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.84624683 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.83811670 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.78312225 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.76902138 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.69414023 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.68615993 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.68545076 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.59257940 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.53679171 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.44219153 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.43666427 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.33864041 |
| 30 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.33250225 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.32115903 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.30230432 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.30021754 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.23040261 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.22925862 |
| 36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.20325507 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.19103879 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 1.11743234 |
| 39 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.11472478 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.10014803 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07779693 |
| 42 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.04775589 |
| 43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.04686253 |
| 44 | Glioma_Homo sapiens_hsa05214 | 1.02061871 |
| 45 | Axon guidance_Homo sapiens_hsa04360 | 1.01859762 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.99670736 |
| 47 | Melanogenesis_Homo sapiens_hsa04916 | 0.98208799 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95810415 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91227731 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.91116903 |
| 51 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.90146354 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87381129 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87320921 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83071229 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82932055 |
| 56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77771178 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75544684 |
| 58 | Alzheimers disease_Homo sapiens_hsa05010 | 0.73941370 |
| 59 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.71993030 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71595834 |
| 61 | Circadian rhythm_Homo sapiens_hsa04710 | 0.68252000 |
| 62 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67975864 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66286554 |
| 64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66046211 |
| 65 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63733911 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62607719 |
| 67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59987630 |
| 68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58946279 |
| 69 | Histidine metabolism_Homo sapiens_hsa00340 | 0.58807965 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57516758 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56535741 |
| 72 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55334035 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.54923305 |
| 74 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53830749 |
| 75 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53700553 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51921787 |
| 77 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51536315 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50171260 |
| 79 | Alcoholism_Homo sapiens_hsa05034 | 0.50158417 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48777522 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.48412399 |
| 82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48198712 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47435424 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46548199 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45718267 |
| 86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45469972 |
| 87 | Parkinsons disease_Homo sapiens_hsa05012 | 0.44526779 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.42588048 |
| 89 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.41730593 |
| 90 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.41187139 |
| 91 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39633168 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39334424 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39257725 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38846100 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38710263 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38481932 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38425216 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.38132624 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.36626626 |
| 100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36558970 |
| 101 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.35711046 |
| 102 | Huntingtons disease_Homo sapiens_hsa05016 | 0.35573155 |
| 103 | Tight junction_Homo sapiens_hsa04530 | 0.35027798 |
| 104 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.33767772 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33703013 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32047301 |
| 107 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31833405 |
| 108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.29369110 |
| 109 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.29204578 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.28822783 |
| 111 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.28775991 |
| 112 | Bile secretion_Homo sapiens_hsa04976 | 0.28204728 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.27146768 |
| 114 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26509211 |
| 115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26461229 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.25903782 |
| 117 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.25116278 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24942302 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24732082 |
| 120 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.23113119 |

